Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project. (Article, 2007) [University of Maryland, College Park]
skip to content
Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.
ClosePreview this item

Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.

Author: S Robinson Affiliation: Health Economics Facility, Health Services Management Centre, University of Birmingham, 40 Edgbaston Park Road, Birmingham, UK. s.m.robinson@bham.ac.ukChlamydia Screening Studies ClaSS Project GroupT RobertsP BartonS BryanAll authors
Edition/Format: Article Article : English
Publication:Sexually transmitted infections, 2007 Jul; 83(4): 276-81
  Peer-reviewed
Other Databases: WorldCatWorldCatAcademic Search Complete
Summary:
BACKGROUND AND OBJECTIVE: Most economic evaluations of chlamydia screening do not include costs incurred by patients. The objective of this study was to estimate both the health service and private costs of patients who participated in proactive chlamydia screening, using mailed home-collected specimens as part of the Chlamydia Screening Studies project. METHODS: Data were collected on the administrative costs of  Read more...
Getting this item's online copy... Getting this item's online copy...

Find a copy in the library

Getting this item's location and availability... Getting this item's location and availability...

WorldCat

Find it in libraries globally
Worldwide libraries own this item

Details

Document Type: Article
All Authors / Contributors: S Robinson Affiliation: Health Economics Facility, Health Services Management Centre, University of Birmingham, 40 Edgbaston Park Road, Birmingham, UK. s.m.robinson@bham.ac.uk; Chlamydia Screening Studies ClaSS Project Group; T Roberts; P Barton; S Bryan; J Macleod; A McCarthy; M Egger; E Sanford; N Low
ISSN:1368-4973
Language Note: English
Unique Identifier: 162104898
Awards:

Abstract:

BACKGROUND AND OBJECTIVE: Most economic evaluations of chlamydia screening do not include costs incurred by patients. The objective of this study was to estimate both the health service and private costs of patients who participated in proactive chlamydia screening, using mailed home-collected specimens as part of the Chlamydia Screening Studies project. METHODS: Data were collected on the administrative costs of the screening study, laboratory time and motion studies and patient-cost questionnaire surveys were conducted. The cost for each screening invitation and for each accepted offer was estimated. One-way sensitivity analysis was conducted to explore the effects of variations in patient costs and the number of patients accepting the screening offer. RESULTS: The time and costs of processing urine specimens and vulvo-vaginal swabs from women using two nucleic acid amplification tests were similar. The total cost per screening invitation was 20.37 pounds (95% CI 18.94 pounds to 24.83). This included the National Health Service cost per individual screening invitation 13.55 pounds (95% CI 13.15 pounds to 14.33) and average patient costs of 6.82 pounds (95% CI 5.48 pounds to 10.22). Administrative costs accounted for 50% of the overall cost. CONCLUSIONS: The cost of proactive chlamydia screening is comparable to those of opportunistic screening. Results from this study, which is the first to collect private patient costs associated with a chlamydia screening programme, could be used to inform future policy recommendations and provide unique primary cost data for economic evaluations.
Retrieving notes about this item Retrieving notes about this item

Reviews

User-contributed reviews

Tags

All user tags (2)

View most popular tags as: tag list | tag cloud

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.